• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

SCH563705 Inhibitor – SCH 563705

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5755518

SCH 563705 is an effective and orally available CXCR2 and CXCR1 antagonist (IC50s: 1.3nM, 7.3nM and Kis of 1 and 3nM, respectively). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
SCH 563705 (SCH563705), Inhibitor
Full Product Name
SCH 563705
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
425.48
Solubility
DMSO: 30mg/mL (70.51mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C23H27N3O5
SMILES
O=C(C(NC1=CC=CC(C(N(C)C)=O)=C1O)=C2N[C@H](CC)C3=CC(C(C)C)=CO3)C2=O
CAS Number
473728-58-4
Target & IC50
CXCR2: ic50 1.3nM
CXCR1: ic50 7.3nM
Mouse CXCR2: ic50 5.2nM
In Vitro
SCH 563705 has good oral pharmacokinetic profiles in rats, mice, monkeys, and dogs. SCH563705 (3-30mg/kg p.o) treatment, causes a dose-dependent elevation in plasma levels of CXCL1. SCH 563705 (50mg/kg p.o) decreases blood Ly6G+ Ly6C+ neutrophil frequency and unchanged levels of Ly6GLy6Chi monocytes [1][2].

Structure of SCH563705, inhibitor

SCH563705 Inhibitor – Cat# MBS5755518

Product References and Citations for SCH563705, inhibitor

Chao J, et al. C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists. Bioorg Med Chem Lett. 2007 Jul 1;17(13):3778-83.
Chao J, et al. C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists. Bioorg Med Chem Lett. 2007 Jul 1;17(13):3778-83.
Min SH, et al. Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis. Biochem Biophys Res Commun. 2010 Jan 1;391(1):1080-6.
Min SH, et al. Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis. Biochem Biophys Res Commun. 2010 Jan 1;391(1):1080-6.

Other Notes

Small volumes of SCH563705, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for SCH563705 purchase

MBS5755518 is an inhibitor targeting SCH563705. Also known as SCH 563705.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000